Latest filing published 04 Sept 2024 for Teladoc Health, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Daniel Trencher, listed as senior executive, appears in our data through filings on Teladoc Health, Inc. shares, published by SEC (Form 4). Between 10 May 2021 and 30 August 2024, the trades on record add up to 43 filings.
The open-market record consists of 25 sales worth €593k, with no purchase. Besides market trades, the filings include 18 option exercises. So far in 2024, the count stands at no purchases and 5 sales.
The record was last updated on 4 September 2024 with an option exercise in Teladoc Health, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 43 declarations